Disposition of tradable shares by Choong Choon Hau of Titan Pharmaceuticals at 9.32 subject to Rule 16b-3
| TTNP Stock | USD 3.98 0.06 1.53% |
Slightly above 60% of all Titan Pharmaceuticals' retail investors are looking to take a long position. The analysis of overall sentiment of trading Titan Pharmaceuticals stock suggests that some investors are interested at this time. Titan Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Titan Pharmaceuticals. Many technical investors use Titan Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Titan |
Filed transaction by Titan Pharmaceuticals 10 Percent Owner. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Titan Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Titan Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Titan Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Titan Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Titan Pharmaceuticals Fundamental Analysis
We analyze Titan Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Titan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Titan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Titan Pharmaceuticals is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Titan Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Titan Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Titan Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Titan Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Titan Pharmaceuticals Related Equities
| INDP | Indaptus Therapeutics | 6.33 | ||||
| FHTX | Foghorn Therapeutics | 4.75 | ||||
| CVKD | Cadrenal Therapeutics, | 3.20 | ||||
| PCSA | Processa Pharmaceuticals | 1.85 | ||||
| SABS | SAB Biotherapeutics | 1.18 | ||||
| THRD | Third Harmonic | 0.88 | ||||
| GOVX | GeoVax Labs | 2.70 | ||||
| KTTA | Pasithea Therapeutics | 4.92 | ||||
| LIXT | Lixte Biotechnology | 7.14 | ||||
| SLRX | Salarius Pharmaceuticals | 12.20 | ||||
| QNRX | Quoin Pharmaceuticals | 13.89 | ||||
| SNTI | Senti Biosciences | 17.76 |
Additional Tools for Titan Stock Analysis
When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.